ARDS

Respiratory·MeSH: Acute Lung Injury

14 drugs in development·12 companies·8 clinical trials

Drug Pipeline by Phase

Approved(3)

Phase 3(3)

Preclinical(6)

Drug	Company
cb5064 analogs	COHBAR, INC. (COBU)
hemoglobin-based artificial oxygen carriers	SANGUI BIOTECH INTERNATIONAL INC (SGBI)
ltx-608	TALPHERA, INC. (TLPH)
php-303	Peak Bio, Inc. (PKBO)
ProLectin-A	BIOXYTRAN, INC (BIXT)
sbt102	SANGUI BIOTECH INTERNATIONAL INC (SGBI)

Unknown(2)

Drug	Company
Allogeneic MSC therapy platform	BioCardia, Inc. (BCDA)
NoveCite	Citius Pharmaceuticals, Inc. (CTXR)

BioSniper tracks 14 drugs in development for ARDS across 12 companies.

There are 8 clinical trials targeting ARDS tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.